Fennec Pharmaceuticals Inc. (FENC) Financials

FENC Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 19.0 million 29.6 million
2023-06-30 19.4 million 29.2 million
2023-03-31 21.8 million 29.2 million
2022-12-31 26.9 million 29.5 million

FENC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.7 million 865000
2023-06-30 -3.9 million 2.5 million
2023-03-31 -5.6 million 1.1 million
2022-12-31 -6.8 million 827000

FENC Net Income

No data available :(

FENC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 12.4 million - 28000
2023-06-30 15.0 million 24.7 million -
2023-03-31 18.4 million 24.7 million -
2022-12-31 23.8 million - -

FENC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 26.5 million
2023-06-30 26.5 million
2023-03-31 26.6 million
2022-12-31 26.3 million

FENC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 12000 3.8 million 3.4 million
2023-06-30 - 8000 5.5 million 2.3 million
2023-03-31 - 4000 4.3 million 2.5 million
2022-12-31 - 117000 4.7 million 2.8 million

FENC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 6.5 million 331000
2023-06-30 3.3 million 148000
2023-03-31 1.7 million 95000
2022-12-31 1.5 million 86000

FENC

Price: $9.23

52 week price:
6.30
11.92

Earnings Per Share: -0.75 USD

P/E Ratio: -12.53

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 138134

Ebitda: -2.2 million

Market Capitalization: 289.1 million

Links: